Director David Morton Fox purchases 3,537 shares at $14.11 avg; holdings rise 18.9% to 22,283 shares
David Morton Fox, a Director at MediWound Ltd., executed 3 separate purchases totaling 3,537 shares for $49,900.57 on 2026-06-01 at a blended average price of $14.11. His post-transaction holdings increased to 22,283 shares, representing an 18.9% increase from his pre-transaction base of 18,746 shares. The current stock price is $13.82, placing the company 38.6% below its 52-week high of $22.50 and down 19.6% over the past 90 days, providing context for the purchase. The transaction's relevance to investors lies in observing the director's capital allocation during a period of sustained price decline, though the Form 4 filing itself does not disclose the director's stated rationale or any non-public information that may have motivated this acquisition.